Pentraxin 3 as a biomarker for acute coronary syndrome: Comparison with biomarkers for cardiac damage

Journal of Cardiology - Tập 58 Số 1 - Trang 38-45 - 2011
Noriaki Kume1, Hirokazu Mitsuoka1, Kazutaka Hayashida1, Masaru Tanaka2
1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
2Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Libby, 2001, Current concepts of the pathogenesis of the acute coronary syndromes, Circulation, 104, 365, 10.1161/01.CIR.104.3.365

Falk, 1995, Coronary plaque disruption, Circulation, 92, 657, 10.1161/01.CIR.92.3.657

Mach, 1997, C-reactive protein as a marker for acute coronary syndromes, Eur Heart J, 18, 1897, 10.1093/oxfordjournals.eurheartj.a015198

Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 836, 10.1056/NEJM200003233421202

Miyao, 1993, Elevated plasma interleukin-6 levels in patients with acute myocardial infarction, Am Heart J, 126, 1299, 10.1016/0002-8703(93)90526-F

Mallat, 2002, Increased plasma concentrations of interleukin-18 in acute coronary syndromes, Heart, 88, 467, 10.1136/heart.88.5.467

Masaki, 2011, Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation, J Cardiol

Yamashita, 2010, N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency, J Cardiol, 55, 377, 10.1016/j.jjcc.2010.01.008

Hayashida, 2005, Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome. A novel marker for early diagnosis, Circulation, 112, 812, 10.1161/CIRCULATIONAHA.104.468397

Ueda, 2006, ELISA for soluble form of lectin-like oxidized LDL receptor-1, a novel marker of acute coronary syndrome, Clin Chem, 52, 1210, 10.1373/clinchem.2005.064808

Nakamura, 2010, Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay, J Pharm Biomed, 51, 158, 10.1016/j.jpba.2009.06.019

Kume, 2010, Soluble lectin-like oxidized low density lipoprotein receptor-1 (sLOX-1) predicts prognosis after acute coronary syndrome—a pilot study, Circ J, 74, 1399, 10.1253/circj.CJ-09-0924

Kume, 2010, Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—comparison with other biomarkers, J Cardiol, 56, 159, 10.1016/j.jjcc.2010.05.002

Rolph, 2002, Production of the long pentraxin PTX3 in advanced atherosclerotic plaques, Arterioscler Thromb Vasc Biol, 22, e10, 10.1161/01.ATV.0000015595.95497.2F

Peri, 2000, PTX3. A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans, Circulation, 102, 636, 10.1161/01.CIR.102.6.636

Inoue, 2007, Establishment of high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris, Arterioscler Thromb Vasc Biol, 27, 161, 10.1161/01.ATV.0000252126.48375.d5

Matsui, 2010, Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction, Atherosclerosis, 210, 220, 10.1016/j.atherosclerosis.2009.10.033

Latini, 2004, Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction, Circulation, 110, 2349, 10.1161/01.CIR.0000145167.30987.2E

Ohman, 1996, Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators, N Engl J Med, 335, 1333, 10.1056/NEJM199610313351801

Antman, 1998, Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11A substudy, J Am Coll Cardiol, 31, 326, 10.1016/S0735-1097(97)00485-3

McCann, 2008, Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T, Eur Heart J, 29, 2843, 10.1093/eurheartj/ehn363

Haltern, 2010, Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction, Am J Cardiol, 105, 1, 10.1016/j.amjcard.2009.08.645

Niizeki, 2007, Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics, Circ J, 71, 1452, 10.1253/circj.71.1452

Dekker, 2010, Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal, Heart, 96, 1001, 10.1136/hrt.2009.189886

Reichlin, 2009, Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N Engl J Med, 361, 858, 10.1056/NEJMoa0900428

Keller, 2009, Sensitive troponin I assay in early diagnosis of acute myocardial infarction, N Engl J Med, 361, 868, 10.1056/NEJMoa0903515